Oragenics, Inc. to Explore Strategic Alternatives for its OTC Probiotic Products Business

By: via Benzinga
Florida-based biopharmaceutical company Oragenics, Inc. (NYSE:MKT – OGEN) has announced today that its board of directors has authorized ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.